{"id":4696,"date":"2018-11-08T16:40:27","date_gmt":"2018-11-08T15:40:27","guid":{"rendered":"https:\/\/www.tarosdiscovery.com\/unkategorisiert\/targeted-stabilizers-of-protein-protein-interactions-as-a-novel-class-of-therapeutic-agents-and-basic-research-tool-compounds\/"},"modified":"2024-01-26T11:18:01","modified_gmt":"2024-01-26T10:18:01","slug":"targeted-stabilizers-of-protein-protein-interactions-as-a-novel-class-of-therapeutic-agents-and-basic-research-tool-compounds","status":"publish","type":"post","link":"https:\/\/www.tarosdiscovery.com\/de\/news\/targeted-stabilizers-of-protein-protein-interactions-as-a-novel-class-of-therapeutic-agents-and-basic-research-tool-compounds-2\/","title":{"rendered":"Targeted Stabilizers of Protein-Protein Interactions as a Novel Class of Therapeutic Agents and Basic Research Tool Compounds"},"content":{"rendered":"\t\t
Dario Valenti, Stanimira Hristeva, Anna Karawajczyk, Dimitrios Tzalis<\/p>\n
91Ö±²¥, TASPPI<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Abstract:<\/strong><\/p>\n Protein-protein interactions (PPIs) are involved in a wide range of human biological processes and related possible pathologies. Medizinalchemie<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Das internationale Team von 91Ö±²¥ verf\u00fcgt kombiniert \u00fcber mehr als 180 Jahre Erfahrung in der pharmazeutischen F&E. Als Team haben wir an mehr als 120 biomolekularen\u2026<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Performance Chemicals<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t Wir entwickeln mit Ihnen Performance Chemicals zur Verbesserung Ihrer Materialien, Kunststoffe, Beschichtungen, Farbstoffe und Druckfarben\u2026<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Therefore, PPIs\u2019 modulation by small molecules is a crucial topic in drug discovery. Modulation of protein-protein interactions means to push the equilibrium between the free proteins and the complex toward one of these two states (Figure 1). There are two strategies to accomplish that: inhibition and stabilisation.
In contrast to the inhibition of PPIs, the stabilisation approach has not yet been exploited in a systematic way. Thus, the TASPPI consortium is aiming to identify chemical stabilizers for providing new crucial therapeutic strategies in the Horizon 2020 key areas of \u201cAgeing Population\u201d (neurodegeneration and cancer) and \u201cIncreased Burden of Chronic Diseases\u201d (metabolic disorders and inflammation). The main targets of the consortium are 14-3-3 protein and its complexes with different protein partners.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\tInteressiert Sie diese Publikation? Kontaktieren Sie unsere Wissenschaftler<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tWirkstoffforschung<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\tMaterialwissenschaft<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t